|
|
Therapeutic Applications of Mannan-Binding Lectin
Organizer:
David C. Kilpatrick (Edinburgh, UK)
Sponsors:
The Biochemical Society
Scottish National Blood Transfusion Service
|
Session one
Chair:
Brian Beechey (Liverpool, UK)
08:30 - 09:05 Registration and Coffee
Brian Beechey (Liverpool, UK)
David C. Kilpatrick (Edinburgh, UK)
Biochemistry and genetics of MBL
Robert B. Sim (Oxford, UK)
Anti-microbial activities of MBL
Dominic L. Jack (Sheffield, UK)
12:40 - 13:45 Lunch and Poster Session
|
Session two
Chair:
Bob Perry (Edinburgh, UK)
08:30 - 09:05 Registration and Coffee
MBL production from human plasma
Inga Laursen (Copenhagen, Denmark)
Recombinant MBL for replacement therapy
Jens C. Jensenius (Aarhus, Denmark)
12:40 - 13:45 Lunch and Poster Session
|
Session three
Chair:
Tessa Holyoake (Glasgow, UK)
08:30 - 09:05 Registration and Coffee
12:40 - 13:45 Lunch and Poster Session
Targeting tumour-associated carbohydrate epitopes using engineered forms of Mannose-binding protein
Oral Communication - Russell Wallis (Oxford, UK)
Association of Decreased Serum MBL with Postoperative Infections
Oral Communication - Michael Siassi
MBL infusion into humans - phase I study
Helgi Valdimarsson (Reykjavik, Iceland)
Clinical potential of MBL replacement therapy
John A. Summerfield (London, UK)
|
Session four
Chair:
David Kilpatrick (Edinburgh, UK)
12:40 - 13:45 Lunch and Poster Session
|